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1 
Abstract (217) 26 
Hypoxia-stimulated erythropoiesis, such as that observed when red blood cell volume (RCV) 27 
increases in response to high altitude exposure, is well understood while the physiologic 28 
importance is not. Maximal exercise tests are often performed in hypoxic conditions following 29 
some form of RCV manipulation in attempt to elucidate oxygen transport limitations at moderate 30 
to high altitudes. Such attempts, however, have not made clear the extent to which RCV is of 31 
benefit to exercise at such elevations. Changes in RCV at sea level clearly have direct influence 32 
on maximal exercise capacity. At elevations above 3,000 m, however, the evidence is not that 33 
clear. Certain studies demonstrate either a direct benefit or decrement to exercise capacity in 34 
response to an increase or decrease, respectively, in RCV; whereas, other studies report 35 
negligible effects of RCV manipulation on exercise capacity. Adding to the uncertainty 36 
regarding the importance of RCV at high altitude is the observation that Andean and Tibetan 37 
high-altitude natives exhibit similar exercise capacities at high altitude (3,900 m) even though 38 
Andean natives often present with a higher percent hematocrit (Htc) when compared to both 39 
lowland natives and Tibetans. The current review summarizes past literature that has examined 40 
the effect of RCV changes on maximal exercise capacity at moderate to high altitudes, and 41 
discusses the explanation elucidating these seemingly paradoxical observations. 42 
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2 
arteriovenous oxygen difference (a-v O2); alveolar to arterial PO2 difference (A-aDO2); mixed 49 
venous partial pressure of oxygen (PvO2); arterial oxygen content (CaO2); diffusive capacity of 50 
oxygen of skeletal muscle (DmO2); exercise-induced arterial hypoxemia (EIAH); minute 51 
ventilation (VE); oxygen consumption (VO2); maximal oxygen consumption (VO2max); time to 52 
exhaustion (TTE); erythropoiesis stimulating agent (ESA); erythropoietin (EPO); erythropoiesis-53 
stimulating agent (ESA); novel erythropoiesis stimulating protein (NESP); recombinant human 54 
erythropoietin (rhEpo); central nervous system (CNS); not significant (NS); whole body (WB); 55 
not applicable (N/A); leg blood flow (LBF), two leg blood flow (2LBF); systemic vascular 56 
conductance (SVC), leg vascular conductance (LVC); mean arterial pressure (MAP); heart rate 57 
(HR); cardiac output (Q); kilopond per meter (kpm); respiratory exchange ratio (RER); treatment 58 
(Tx); lactate concentration ([La]); Watts (W); hypoxia-inducible factor 2 alpha (HIF-2α); sea 59 
level (SL); intermittent hypoxia (IH) 60 
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3 
Introduction 72 
The study of both acclimatization and adaptation to hypoxia in humans is a timely topic of 73 
current research. Approximately 16.5 million km2 of the earth’s surface exists at or above an 74 
elevation of 2,000 m 1. More importantly, between 140 and 150 million people reside at these 75 
high altitudes, while another 35 million lowland dwellers visit or commute to elevation above 76 
3,000 m annually 2, 3. Exposure of humans to such altitudes is a challenge to homeostatic 77 
maintenance of oxygen flux as a result of the gradual decrease in the partial pressure of oxygen 78 
(PO2) attendant to the diminishing barometric pressure 4. Our understanding regarding the 79 
physiologic importance of red blood cell volume (RCV) at high altitudes is important, as the 80 
erythrocyte is the primary means of transporting oxygen from the environment to respiring cells. 81 
In this review, RCV is referring to the total number of erythrocytes in the blood as oppose to 82 
volume of individual red blood cells. Research examining this area of interest has presented 83 
seemingly conflicting results.  84 
 85 
The overall aims of this review are as follows: i) To review maximal exercise capacity near sea 86 
level (0 to 500 m), and the effect of increasing RCV in these conditions; ii) To introduce the 87 
topic of study regarding the function of RCV and exercise capacity at elevations ranging in 88 
between 2,000 to 5,500 m; iii) To summarize the literature that has studied the role of RCV 89 
manipulation on the ability to exercise at elevations ranging from moderate to high altitude; and 90 
iv) To discuss these seemingly paradoxical observations.  91 
 92 
The initial set of studies included in the review were retrieved through a search of PubMed and 93 
Web of Science using the keywords acclimatization, exercise, high altitude, percent hematocrit 94 
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(Htc), and red blood cell. Only those studies that had corresponding measurements of exercise 95 
performance with Htc, total hemoglobin (Hb) mass, or total arterial oxygen content (CaO2) at 96 
baseline, and following an intervention (e.g., acclimatization to a given altitude, hemodilution, 97 
blood infusion, or erythropoietin (EPO) administration) fulfilled our criteria, and were selected. 98 
Preferable studies were those that had measurements for either Htc, or total Hb mass in 99 
conjunction with CaO2. From those primary studies, we established both forward and backward 100 
reference mapping for potential studies of interest that were initially missed through the database 101 
searches. Again, studies of interest were examined, and only those that met the previous 102 
selection criteria were included in this review. Overall, 20 studies fit our criteria and have been 103 
included in this review (Tables 1-4).  104 
 105 
This topic has been presented in several independent studies, but to the best of our knowledge 106 
never collectively in a publication that assembles and interprets all relevant literature together. In 107 
this way, the present review shall contribute to our understanding of the actual impact of RCV 108 
and attendant CaO2 on exercise capacity at altitude. In our effort, we attempt to cover the whole 109 
spectrum of RCV manipulations including acclimatization, acute reductions (hemodilution), 110 
acute expansions (transfusion), and finally more chronic expansion of RCV (via an 111 
erythropoiesis-stimulating agent, ESA), and how these manipulations affect exercise at moderate 112 
to high altitude. The limitation of this review is the lack of data dealing with exercise capacity in 113 
polycythemic highlanders prior to, and following hemodilution. This may be of interest for 114 
future research. 115 
 116 
 117 
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The relationship between oxygen transport and exercise capacity from sea level to higher 118 
elevations 119 
Exercise capacity at sea level tightly correlates with RCV 5. The fact that an individual’s aptitude 120 
for exercise, both maximally 6-12 and/or submaximally 6, 7, 9, 11, 13, improves near sea level 121 
following increases in RCV is well understood 14. This improvement in exercise performance is 122 
mostly a direct result of the increase in CaO2 that is concomitant to increases in RCV 8-10, 15-17. 123 
Alternative means of adjusting CaO2, such as hyperoxic breathing, increases exercise 124 
performance not only at sea level, but also at higher elevations 18, 19; though the added bulk of 125 
equipment necessary for oxygen supplementation is not conducive for most exercising athletes. 126 
Interestingly there is evidence suggesting that hyperoxic breathing may be more advantageous 127 
when attempting to improve maximal oxygen consumption (VO2max) than methods used to 128 
increase RCV, such as blood transfusions, or treatment with an ESA. The ratio of ΔVO2max per 129 
ΔCaO2 appears greater with hyperoxic breathing (2.06) 18, 19 when compared to increases in RCV 130 
(0.70) 8-11, 17 at sea level. Maximal workload has also been shown to significantly increase (233 ± 131 
15 W to 283 ± 18W) after acclimatization to 5,260 m when increasing hyperoxic breathing from 132 
21% to 55% oxygen independent of any change in leg VO2max 20. Future studies manipulating 133 
RCV, and the partial pressure of arterial oxygen (PaO2), while maintaining CaO2 will help to 134 
clarify the rate limiting mechanism(s) of maximal exercise in various environments. The limited 135 
evidence suggests that diffusion limitations at the level of the skeletal muscle, even at sea level, 136 
may be greater than previously assumed, though they are easily overshadowed by convective 137 
limitations of oxygen transport. 138 
 139 
While convective limitations in oxygen delivery have dominated scientific dogma in regards to 140 
6 
our understanding of a physiologic bottleneck limiting exercise capacity, it is important to 141 
acknowledge and identify diffusive limitations of oxygen flux that occur as well. For instance, in 142 
some fit to elite athletes a pulmonary limitation exists during exercise at sea level 21-23. 143 
Ventilation-perfusion inequality and alveolar-end-capillary oxygen diffusion limitation increase 144 
along with exercise intensity 24-26 resulting in exercise-induced arterial hypoxemia (EIAH). 145 
EIAH is defined as a drop in arterial oxygen saturation (SaO2) ranging from 95% (mild) to less 146 
than 88% (severe) 27, 28. The degree of EIAH positively correlates with training status and has 147 
been observed at both maximal 29 and submaximal exercise intensities 22, 23. Individuals that 148 
display EIAH during sea level exercise exhibit a more profound reduction in VO2max at 149 
elevations above sea level that is apparent even when going to a low altitude of 1,000 m. 150 
Conversely, individuals that maintain SaO2 during maximal exertion at sea level experience 151 
negligible decrements in VO2max with an equivalent 1,000 m increase in elevation 30.  152 
 153 
Hitherto, the principal factors limiting the maximal capacity for exercise at sea level has largely 154 
been attributed to the convective limitations of oxygen transport as opposed to the diffusive 155 
limitations at any point from the environment to the mitochondria, namely the lung and skeletal 156 
muscle 16, 31-33. This concept has been tested and challenged in regards to exercise performance at 157 
higher elevations. 158 
 159 
Optimal hematocrit for exercise performance 160 
The rheological properties of blood throughout the vascular network are not static and fluctuate 161 
according to vessel diameter. Htc and viscosity both decrease with diminishing vessel diameter, 162 
known as Fahraeus effect 34 and the Fahraeus–Lindqvist effect 35, respectively. Accordingly, 163 
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capillary Htc is significantly lower than systemic Htc 36. An additional mechanism responsible 164 
for Htc heterogeneity in the microcirculation is the unequal division of red cell and plasma 165 
volumes at arterial bifurcations. This uneven separation, referred to as plasma skimming, with 166 
the daughter branch receiving a greater proportion of blood flow, also results in a 167 
disproportionately high distribution of erythrocytes 37-39. How these phenomena influence 168 
oxygen diffusion at the tissue, especially at moderate to high altitude, is unknown. Discussion of 169 
blood characteristics in this review refer to those measured in relatively large systemic vessels.  170 
 171 
The optimal Htc for exercise performance is the Htc at which exercise capacity is maximized. 172 
Near sea level the optimal Htc has been proposed to occur when CaO2 and cardiac output are 173 
collectively the greatest 40-43. The first study to ascertain an actual optimal Htc for both sea level 174 
VO2max and endurance capacities (time to exhaustion; TTE) in vivo established that the 175 
relationship between the exercise capacity and Htc in a mouse model is parabolic 44; exercise 176 
capacity improves with increasing Htc to a point where further increases begin to hinder 177 
maximal exercise capabilities (Fig. 1) due to increasing viscosity of the blood. The optimal Htc 178 
for maximal performance was observed at 57 and 68 % depending on acute or chronic presence 179 
of EPO in the animal’s circulation 44.  180 
 181 
At higher elevations (i.e. 3,800 m), optimal Htc is theorized to occur as the mixed venous partial 182 
pressure of oxygen (PvO2), in respect to Hb concentration ([Hb]), is maximized 45. At an 183 
elevation of 4,724 m, heart rate of subjects was shown to decrease as Htc increased from 46 to 184 
59%, and then reciprocally increase as Htc subsequently fell during stable submaximal exercise 185 
with the lowest submaximal heart rate occurring at Htc of 59%. While these observations were 186 
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indicative that increased Htc improved submaximal exercise performance, the value of 59% was 187 
never confirmed as an optimal Htc 46.The theoretical constructs of an optimal Htc for exercise 188 
performance has been discussed in the past 7, 20, 40-42, 45, 47, 48 although this had never been directly 189 
measured in humans.  190 
 191 
During exercise Htc may increase.  Exercise induced hemoconcentration in humans occurs 192 
primarily from a transient shift of fluid from intravascular to extravascular compartments 193 
concomitant to increased blood flow, capillary perfusion, and increased filtration of both 194 
cutaneous and muscle capillary beds 49, but also to the slight contribution of erythrocytes from 195 
adrenergic stimulated splenic contraction 50, 51, and fluid loss through sweat with prolonged 196 
exercise. Unlike athletically endowed animals, such as the dog and horse, who can increase Htc 197 
(25-50%) during exercise by splenic contraction, thus allowing for an increase in VO2max (10-198 
30%) 52, exercise induced hemoconcentration in humans is small but significant with Htc 199 
increasing around 4-6% 50, 51, and both arterial [Hb] and oxygen carrying capacity improving by 200 
approximately 10% 53, 54. As mentioned above, the optimal Htc for maximizing exercise 201 
performance near sea level was found to be approximately 58% in ESA-treated wild type mice 202 
44. Whether or not this value is transferable to humans is unknown, but this Htc far exceeds 203 
normal Htc in healthy male/females at rest (40-45% / 37-42%) and during exercise (45-50%/42-204 
47%).  205 
 206 
One past gold medal winning Olympic athlete possessed an autosomal dominant mutation in the 207 
EPO receptor that led to increased sensitivity of erythroid progenitors to EPO, and constitutively 208 
elevated [Hb] (231 g/l) and a Htc (68%) similar to the optimal Htc detected in mice that 209 
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constitutively overexpress EPO. This athlete displayed an exceptional aptitude for exercise 210 
together with such hematological parameters 55. This heightened [Hb] corresponds to an 211 
estimated CaO2 at sea level of 30 ml of oxygen per dl of blood oppose to the approximate 20 212 
ml/dl given that this athlete possessed a more common value of [Hb], 15 dl/ml, which 213 
precipitates roughly a 67% increase in locomotor oxygen delivery during exercise.  214 
 215 
Apart from genetic disorders, the optimal Htc for exercise in mice at sea level is much closer to 216 
the Htc following acclimatization to high altitude that, dependent on elevation, can reach values 217 
ranging from 50-55% or above 20, 56-59. Nevertheless, the extent to which increases in RCV and, 218 
more importantly, the attendant increases in CaO2 have on exercise performance at varying 219 
degrees of altitude above sea level still remains unclear. 220 
 221 
Acclimatization and RCV 222 
Although hypoxia-induced erythropoiesis is highlighted in this discussion, it is important to keep 223 
in mind that acclimatization to elevations ranging from low to extreme altitude is an 224 
exceptionally complex and integrative process of which is still being studied. In addition to 225 
erythropoiesis 59, 60, acclimatization includes, but is not limited to, alteration in ventilation and 226 
gas exchange 61-65, cardiovascular and hemodynamic function 66, 67, autonomic outflow 68, 69 227 
skeletal muscle morphology and biochemical expression 70-75, neuroendocrine regulation 76, and 228 
nutrient partitioning 77. All these observable changes following acclimatization collectively 229 
modify physiologic homeostasis as well as one’s capacity for exercise. Accordingly, the aim of 230 
this review is to provide new insights into the role of RCV on performance at moderate to high 231 
altitude and the underlying mechanism(s) attributable to the measured outcomes. This is 232 
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important seeing as how the relevant studies summarized in this review have utilized hypobaric 233 
hypoxia 46, acute hypoxic breathing 15, 16, 40, 47, 78, 79, and experimentation at actual altitude 20, 56-58, 234 
80-83; the majority of studies investigate different severities and lengths of exposure to the 235 
respective altitude or degree of hypoxia which, very understandably, lead to different physiologic 236 
affects.  237 
 238 
Acclimatization is commonly associated with an increase in RCV although not all high altitude 239 
dwelling mammals express this phenotype. Measurements in high altitude dwelling animals, 240 
such as the llama 84, and high altitude natives including the Tibetans 85 and Ethiopians 86, all 241 
showing values of total Hb mass and Htc that are closer to values observed in lowlanders at sea 242 
level, have led some to question the importance of hypoxia-induced erythropoiesis 20, 56. The 243 
llama’s RCV is more elliptical than disc-shaped resulting in more viscous whole blood at a given 244 
Htc 41. For this reason high altitude dwelling llamas understandably have lower Htc when 245 
compared to humans residing at the same elevation. Differences in Htc between high altitude 246 
native populations are not so clearly understood.  247 
 248 
Discordantly to both Ethiopians and Tibetans, Andean natives express a Htc significantly above 249 
sea level values 62, 85, 87, 88. Recent evidence reveals that the gene encoding for hypoxia-inducible 250 
factor 2 alpha (HIF-2α), EPAS-1 89, represents a key gene mutation explaining some of the 251 
differences to adapting and living at high altitudes among different native populations 90-93. 252 
Tibetan and Andean natives exhibit similar maximal exercise capacities at 3,900 m despite 253 
significantly greater CaO2, [Hb], and Htc in the Andean population 94. The maintenance of 254 
exercise capacity despite different hematological parameters may be explained by the gene 255 
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mutation in HIF-2α observed in Tibetans 90-93. It has been speculated that EPO-induced 256 
erythropoiesis has not evolved to cope with high altitude exposure, but to keep a balanced red 257 
blood cell production at or near sea level. Consequently it has been suggested that most humans 258 
are designed to live at or near sea level 95.  259 
 260 
Comparisons of rheological properties between high altitude populations have not been 261 
examined. The influence of hypoxia on the biophysical properties of erythrocytes and whole 262 
blood is unclear. Hypoxia influenced hemorheological adaptations differ between species 96-98 as 263 
well as within species 98-102. It appears that animals and humans susceptible to the development 264 
of high altitude illness have a more pronounced response (i.e., increase in blood viscosity and/or 265 
loss of erythrocyte deformability) 98, 99, 101, 102. Accordingly, a complete examination into 266 
differences in hemorheological compensation between Tibetans, Ethiopians, and Andeans is 267 
merited.  268 
 269 
Aside from intergenetic variability between native high-altitude populations, the majority of 270 
humans experience some degree of erythropoietic activation when exposed to a hypoxic 271 
environment 59. This expansion in RCV occurs slowly over time in lowlanders sojourning to high 272 
altitude. As the availability of oxygen decreases, humans undergo an increase RCV through 273 
activation of erythropoietic precursor cells in bone marrow via EPO 103, which is primarily 274 
expressed by the kidneys. As our understanding of the mechanisms that upregulate EPO, 275 
mediated by HIF-2α 104, 105, has improved, the physiologic significance for this increase in RCV 276 
remains incomplete.  277 
 278 
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What is the relationship between RCV and exercise from low to high altitudes? 279 
The general concept of improving the capacity for exercise at altitude via an increase RCV is 280 
simple. Exercise performance declines linearly from approximately 300 m to 3,000 m 106 with an 281 
average decline in VO2max of 6.4% for every 750 m 80, 106, 107 . The loss of exercise capacity is 282 
even greater at elevations of 3000 m and above 108. Maximal sea level exercise capacity is 283 
directly related to CaO2 14. Thus it seems quite plausible to hypothesize that the loss of exercise 284 
capacity at altitude could be offset if CaO2 was increased via an infusion or up-regulation of 285 
RCV. Clearly this supposition is not entirely true. While several studies have demonstrated a 286 
benefit of higher total Hb mass and Htc on an individual’s capacity for exercise at elevations 287 
above 2,000 m 16, 40, 46, 47, 57, 58, 83, others have reported negligible effects 16, 20, 56, 78, 80, 81. These 288 
studies will be discussed below in more detail. Theoretical computation estimated the value of 289 
[Hb] and Htc to be between 15 - 18 g/dl and 45 - 54%, respectively, in order to optimize CaO2 290 
and oxygen utilization at an elevation of 3,800 m 45. An optimal Htc in humans or animals has 291 
never been directly determined at elevations above 500 m. 292 
 293 
Published findings relating the change in exercise capacity following acclimatization to 294 
elevations above 2,000 m have been seemingly inconsistent. When comparing exercise capacity 295 
at elevations above sea level, both before and then following acclimatization, VO2max has been 296 
shown to increase at 2,300 m 109, 110, 3,800 m 111, and 4,300 m 57, but not after acclimatization to 297 
3,475 m 112, 4,100 m 113, 114, and 4,300 m 77, 115, 116. Regardless, if exercise capacity does improve 298 
pre to post acclimatization, it never returns to sea level values 82, 117, 118.  299 
 300 
Acclimatization and maximal exercise capacity at moderate to high altitudes 301 
13 
The following studies have specifically monitored changes in Htc, [Hb], and/or CaO2 in parallel 302 
with an evaluation of exercise over time, while remaining at a respective altitude. Table 1 303 
summarizes the data from such studies that have investigated changes in Htc, [Hb], and/or CaO2 304 
alongside measurements of exercise capacity comparing an initial/early versus a more chronic 305 
exposure to a particular elevation. Some studies have demonstrated a benefit to exercise capacity 306 
following acclimatization. Four weeks at 2,270 m increased Htc by 7.2% and absolute VO2max by 307 
5.6% above values collected 2 days after exposure to this moderate altitude 119. When comparing 308 
1 versus 16 days acclimatization to 4,300 m, Htc, CaO2, and relative VO2max increased by 12.7%, 309 
18.5%, and 9.9%, respectively 57. Additionally, VO2max increased subsequent to acclimatization 310 
at 4,300 m despite no change in maximal cardiac output 57. When Htc and CaO2 were then 311 
lowered by 10.6% and 8.8%, respectively, via isovolemic hemodilution, VO2max was also 312 
reduced by 8.2% 57. When compared to acute hypoxic exposure, lowland natives acclimatized to 313 
5,260 m demonstrated a 31.3% increase in CaO2 attendant to a 30.4% increase in [Hb] both of 314 
which corresponded to a 13% increase in absolute VO2max 83.  315 
 316 
With the uncertainty concerning RCV, exercise capacity, and well being at higher elevations, the 317 
identification of a “normal” Htc value in high-altitude natives was sought. Subjects volunteering 318 
for this study were residents of and around La Paz, Bolivia (approximately 3,700 m), and were 319 
classified as anemic, normal, or polycythemic dependent upon Htc which averaged to be 42%, 320 
54%, and 65%, respectively 58. Exercise tests were administered to normal and anemic subjects. 321 
The 28.6% higher average Htc in normal subjects corresponded to a 26.9% greater average 322 
absolute VO2max versus anemic subjects 58. Unfortunately the exercise capacity for those that 323 
presented with polycythemia could not be measured.  324 
14 
 325 
Certain sporting events, such as the 1968 summer Olympics in Mexico City, are held at moderate 326 
to high altitudes. Exercise or sport performance that require repetitive and strenuous skeletal 327 
muscle contraction lasting two minutes or more are hindered by a limitation in oxygen 328 
availability 120, 121. Spending time at the respective elevation prior to competition helps to 329 
minimize a decrement in performance. Two to three weeks at 2,300 m improved long distance 330 
running and swimming performance at moderate altitude 110. Contrarily, too much time spent at 331 
high elevations may consequently diminish overall exercise performance 121. Thus, Schuler et al. 332 
(2007) examined the minimum time at moderate altitude necessary to maximize exercise 333 
performance. The most dramatic increases in exercise performance (VO2max, maximal power 334 
output, and time-to-exhaustion (TTE)) occurred following 14 days at 2,340 m. Additionally, all 335 
facets of exercise improvement strongly correlated with the measured changes in Htc and CaO2. 336 
When compared to the first day of arrival, a 10.4% increase in Htc and 11.5% improvement in 337 
CaO2 associated with an increases in absolute VO2max (8.2%; Fig. 2A), maximal power output 338 
(8.9%; Fig 2B), and TTE (12.0%; Fig. 2C) 82, all of which suggest a benefit of an increase Htc 339 
and oxygen carrying capacity on exercise performance at moderate altitude. 340 
 341 
Other studies failed to verify an improvement in exercise capacity following acclimatization and 342 
change in RCV. Compared to acute hypoxic exposure, 15 to 17 days at 4,300 m led to an 343 
increase of [Hb] by 20.3% and CaO2 by 29.2%, but failed to increase VO2max 122. Three weeks at 344 
5,200 m increased both Htc and [Hb], but did not improve relative VO2max values (non-345 
significant increase of 4.1%) 123. Unexpectedly, however, when Htc was then decreased by 2.3% 346 
via oral administration of an isomolar solution, VO2max significantly decreased by 7.3% 123. At 347 
15 
5,050 m, when comparing one week to five weeks of altitude exposure, an 8.0% increase in [Hb] 348 
corresponded to a non-significant increase in absolute VO2max of 13.2% 124. Lastly, despite an 349 
11.3% larger total Hb mass following 6 months of intermittent acclimatization to 3500 m, no 350 
differences in high altitude VO2max were observed when comparing lowland controls to subjects 351 
exposed to intermittent hypoxic125.  352 
 353 
Acclimatization of lowlanders to a respective elevation was thought to lessen the loss of VO2max 354 
to values above those obtained during acute hypoxic exposure 126. Summarization of the 355 
literature fails to verify this belief, however, the loss of exercise capacity as well as the ability to 356 
improve following acclimatization appears to be dependent upon the elevation. Other studies 357 
have manipulated RCV directly, either in the presence or absence of acclimatization, while also 358 
monitoring the attendant changes to exercise capacity. 359 
 360 
Artificial manipulation of RCV and maximal exercise capacity at moderate to high altitude 361 
Examining the role of RCV on exercise capacity at altitude has also been studied by direct 362 
manipulation. Decreasing RCV through the means of hemodilution, as was previously mentioned 363 
57, 123, and/or increasing RCV through various means aside from natural acclimatization such as 364 
direct infusion of blood 40, 47, 80, or by administration of an ESA 16, 78 have all been examined. The 365 
effect on exercise capacity at altitude following either a decrease or an increase in RCV will be 366 
presented categorically dependant upon means of RCV augmentation. 367 
 368 
Hemodilution and maximal exercise capacity 369 
To emphasize the uncertainties regarding the role of RCV on exercise capacity at altitude, 370 
16 
several studies have examined changes to exercise capacity at altitude following hemodilution. 371 
The basis for such experiments was derived from the difference between the theoretical 372 
estimation of 47% as the optimal Htc for human blood 41 opposed to Htc values actually 373 
measured in both high-altitude natives (Aymara) and lowlanders acclimatized to high altitudes 374 
which are typically greater than 50% 20, 56-58. It is hypothesized that for some given Htc the 375 
associated blood viscosity will negate any benefit of enhanced CaO2 due a loss of cardiac 376 
capacity 41, 43 though such a value has never been identified. Transgenic mice that constitutively 377 
overexpress EPO (Tg6) and present with high Htc, 75 to 91%, adapt several mechanisms helping 378 
to maintain normal function despite excessive erythropoiesis and attendant blood viscosity. 379 
These mechanisms include increased erythrocyte flexibility and increased plasma nitric oxide 380 
synthase levels 127-130. Whether or not humans display similar adaptations with high Htc is 381 
unknown. Since an optimal Htc for exercise at different elevations has yet to be identified, some 382 
studies have examined the effect of increasing RCV, while others have attempted the opposite 383 
and decreased an already elevated RCV. Table 2 summarizes the results of such studies. 384 
 385 
Hemodilution in one polycythemic subject at 4,250 m decreased Htc from 62 to 42% (Δ-32.3%) 386 
56. Though VO2max was not reported, isovolemic hemodilution increased heart rate, stroke 387 
volume, cardiac output, breathing frequency, VO2, and respiratory exchange ratio at an absolute 388 
workload of 49 W 56; each change suggestive of a loss in exercise capacity. The authors 389 
suggested otherwise by stating that the ventilatory breakpoint improved following hemodilution 390 
supporting the idea that a decline in RCV improved exercise performance at 4,250 m 56. The 391 
diffusive capacity of oxygen in skeletal muscle (DmO2) in hypoxia (fraction of inspired oxygen, 392 
FiO2, of 12%) was later examined following isovolemic hemodilution. The replacement of 526 393 
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ml of blood with saline effectively reduced [Hb] and CaO2 by 13.2% and 8.8%, respectively 79. 394 
These reductions resulted in a loss of VO2max of approximately 13.5% in addition to a decrease in 395 
DmO2 79. The capacity to perform dynamic two-legged knee extensor exercise was examined 396 
after decreasing Htc (20.9%) and CaO2 (18.9%) during hypoxic (FiO2 of 11%) exercise. Peak 397 
VO2 values diminished by 19.4% 15. The correlation between limb blood flow and CaO2 was 398 
significant (r = 0.99), whereas the relationship between blood flow and PaO2 was not 15. One liter 399 
of blood replaced with Dextran 70 following 9 weeks of acclimatization to 5,260 m 20 decreased 400 
both Htc (25.0%) and CaO2 (23.2%) with no change in VO2max 20.  401 
 402 
Blood viscosity has an important role in hemodynamic control and though blood viscosity was 403 
not measured in the latter study, nor any other studies mentioned in this section, an increase in 404 
plasma viscosity by means of viscogenic plasma expanders may help to maintain vasomotor tone 405 
and microvascular function despite reductions in oxygen delivery 131. This can play a part as to 406 
why VO2max failed to decrease following a loss of oxygen carrying capacity at high altitude.  407 
 408 
Blood transfusions and maximal exercise capacity  409 
Summarized results for studies examining the effect of RCV infusion on exercise capacity at 410 
elevations above sea level are illustrated in Table 3. Initial studies reported a positive affect of 411 
RCV manipulation through acute infusions. In 1945, Lieutenant Pace and colleagues 46 pioneered 412 
the first study that examined the effect of RCV manipulation and the response on exercise 413 
capacity at 4,724 m using a hypobaric chamber. This classic study investigated the effect of a 3-4 414 
day, 2,000 ml RCV transfusion (50% suspension) on heart rate during submaximal exercise 415 
performance at this simulated altitude. The transfusion of RCV significantly increased Htc and 416 
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CaO2 by approximately 28% and 23%, respectively, which significantly lowered heart rates 417 
during submaximal exercise compared to those infused with an equal volume of saline. The 418 
authors suggested that an expansion in RCV via blood transfusion improves exercise tolerance in 419 
hypoxia 46. A blood infusion consisting of 525 ml of packed RCV increased Htc by 26.6% and 420 
improved VO2max by 13.0% in subjects that were subjected to an acute bout of hypoxia (FiO2 of 421 
13.5%) simulating 3,566 m 47. Building upon initial findings, an autologous infusion of 334 ml 422 
of packed erythrocytes increased Htc by 17.8% and improved VO2max by 10.2% in subjects that 423 
were also subjected to an acute bout of hypoxia (FiO2 of 16%) simulating 2,255 m 40.   424 
 425 
Later studies challenged such an effect.  A blood infusion consisting of 295 ml of packed RCV 426 
significantly increased [Hb] by approximately 9% however failed to increase either CaO2 or 427 
VO2max within 10-14 hours of arriving at 4,300 m 80. The RCV infused subjects were reported to 428 
have an average VO2max that was 230 ml/min above saline infused controls (reported as a trend, 429 
no p-value provided) 80.  430 
 431 
Two possible explanations for these findings are: 1.) Out of three studies, the only one to suggest 432 
that RCV infusion doesn’t increase exercise capacity at elevations above sea level infused the 433 
smallest amount of RCV, and was the only study to fail in improving CaO2 80; or 2.) RCV 434 
infusion is effective in improving exercise capacity during acute hypoxic exposures simulating 435 
3,566 and 2,255 m 40, 47, but not at higher elevations such as 4,300 m 80 because of a limitation in 436 
oxygen diffusion.  437 
 438 
ESA and maximal exercise capacity 439 
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The most recent means of expanding RCV in attempt to improve exercise capacity at altitude 440 
consists of treatment with an ESA, which has ostensibly replaced the use of blood transfusions. 441 
The results of these studies are summarized on Table 4. It should be noted that the physiological 442 
effects of EPO extend beyond hematological parameters 132. Whether a non-erythroid effect of 443 
EPO improves exercise capacity is currently under investigation. There is evidence however to 444 
suggest that near sea level the effects of both low dose, long term EPO administration on VO2max 445 
is dependent solely on hematologic changes 10, 133, and that there is even a greater improvement 446 
of submaximal versus maximal exercise performance 11.   447 
 448 
The principle study to have examined the effect of RCV manipulation via an ESA on exercise 449 
performance in acute hypoxia (FiO2 of 12.4%) used weekly subcutaneous injections of novel 450 
erythropoiesis stimulating protein (NESP), which increased Htc and CaO2 by 16.7% and 11.6%, 451 
respectively 78. Despite increases to both Htc and CaO2, VO2max was not affected (Δ0%) at the 452 
simulated elevation of 4,100 m, 78.  453 
 454 
The first and only study to analyze the effect of equivalent changes in RCV on exercise capacity 455 
when exposed to different degrees of hypoxia also used ESA for RCV manipulation 16. The 456 
results of the study are summarized in Table 5. Briefly, 5 weeks of treatment with recombinant 457 
human erythropoietin (rhEpo) increased Htc across 4 separate hypoxic exposures (FiO2: 17.4, 458 
15.3, 13.4 and 11.5% simulating 1,500, 2,500, 3,500, 4,500 m, respectively) during maximal 459 
exercise, whereas CaO2 and VO2max increased in all hypoxic exposures except for the lowest 460 
oxygen concentration, 11.5% 16.  461 
 462 
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Taken together, all the studies that utilized acute manipulations of RCV indicate that from 1,500 463 
m to somewhere between 3,500 and 4,500 m greater RCV improve VO2max during acute 464 
exposure to hypoxia. At some point, however, between elevations of 3,500 and 4,500 m, any 465 
assistance to exercise capacity via greater RCV is seemingly lost.  466 
 467 
Exercise capacity at moderate to high altitude with changes in blood and plasma volume  468 
Total blood volume is comprised predominantly of RCV and plasma volume. Though this review 469 
focuses on the effect of RCV changes on exercise capacity at moderate to high altitudes, plasma 470 
volume also changes at such elevations and merits reference. Ascent to higher elevations incurs a 471 
fairly rapid (4 hours) loss of plasma volume (≈ 20%) that persists while at altitude 59, 118, 134-138. 472 
The loss results, at least transiently, in a reduction in total blood volume. Hypoxic ventilatory 473 
drive increases respiration, and ultimately reduces plasma volume. Insensible water loss 474 
increases linearly with ventilation as does excess carbon dioxide expiration, alkalosis, which is 475 
then offset by renal bicarbonate excretion, and diuresis 139. The loss of plasma assists with 476 
hemoconcentration of the blood so Htc increases independent from erythropoiesis (of which 477 
increases RCV population over several weeks). This plasma loss partially accounts for the initial 478 
weight loss and the drop in cardiac filling pressures of the heart at altitude 140, 141, but has little if 479 
any effect on maximal exercise capacity 142.  480 
 481 
After 9 weeks of acclimatization to 5,260 m, plasma and total blood volume were decreased 482 
from sea level values, and though an infusion of 1 liter 6% dextran increased total blood volume 483 
from an average of 5.40 to 6.32 liters, maximal exercise capacity failed to improve at high 484 
altitude when compared to preinfusion values 118.  Alternatively, after approximately 18 days of 485 
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exposure to high/extreme altitude (7 days at 4,350 m followed by 10-12 days at a simulated 486 
6,000 m), resting plasma volume, but not total blood volume (p = 0.06), was decreased from sea 487 
level values by 25.8% (3.68 ±0.51 liters at sea level to 2.73± 0.63 liters at altitude) and an 488 
infusion of 219±22 ml of Hesteril 6% improved maximal exercise capacity by 9% while at 6,000 489 
m 138.  490 
 491 
Supplemental carbon dioxide (3.77% CO2) during 5 days of simulated hypobaric hypoxia 492 
prevented hemoconcentration and maintained body weight suggesting the maintenance of plasma 493 
volumes 143. Despite maintenance of plasma volume, exercise capacity still diminished by 33% 494 
(3.1 to 2.08 l/min), which was even more than the 29% decrease in subjects exposed to just 495 
hypobaric hypoxia without supplemental carbon dioxide (3.19 to 2.26 l/min) 143. There was a 496 
greater loss of exercise capacity despite no detected loss of stroke volume in the subjects 497 
supplemented with carbon dioxide, while it decreased in those without supplementation 143. 498 
Arterial oxygen tension was the only variable significantly different between the two groups, and 499 
served as the best explanation for the differences in exercise capacity highlighting the 500 
importance of PaO2 on the rate of oxygen diffusion and exercise capacity in hypoxic conditions.  501 
 502 
The indifference of plasma volume on exercise capacity at increasing altitudes is clear, as plasma 503 
volume expansion fails to consistently improve exercise capacity or maximal cardiac output at 504 
moderate to extreme altitude 118, 135, 138 when acute supplementation of 50-100% O2 restores 505 
maximal heart rate 144, work capacity 144, 145, maximal power output, and leg VO2 20, 118 to near 506 
sea level values independent from changes in plasma or total blood volume. This also 507 
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emphasizes the importance of oxygen tension and carrying capacity on exercise performance at 508 
moderate to high altitude. 509 
 510 
Convective versus diffusive limitations of oxygen transport during exercise at elevations 511 
above sea level  512 
The principal limitation to exercise capacity near sea level is understood to be primarily a result 513 
of the convective restraints in oxygen transport such as cardiac output and CaO2 31, 54, 146. The 514 
improvement in exercise capacity at sea level following an increase in RCV, and more 515 
importantly CaO2, becomes less prominent as elevation increases. As elevation increases, the 516 
primary limiting factor of exercise capacity shifts to an insufficient oxygen gradient in which the 517 
ability to drive oxygen diffusion progressively diminishes, i.e., a loss of driving pressure or a 518 
diffusive limitation to oxygen transport, occurring particularly in the lung and skeletal muscle 519 
147. A pressure gradient is the driving force that facilitates oxygen diffusion from the 520 
environment to the lungs, the lungs to circulating Hb within the RCV, and finally from Hb to the 521 
metabolic machinery of the cell. The loss of environmental or ambient oxygen pressure results in 522 
the decrement of driving pressure throughout the entire cascade of oxygen transport.  523 
 524 
By ascending to elevations above sea level, the progressive decrease in pressure gradient reduces 525 
the rate of oxygen diffusion, ultimately limiting oxygen flux and constraining maximal cellular 526 
respiration capacities. At high to extreme altitudes, the diffusive limitations of oxygen offset any 527 
increase in oxygen carrying capacity via erythrocyte infusion, EPO administration, or even 528 
acclimatization. Opposingly, and further underscoring the limitation in pressure gradient at high 529 
to extreme altitude, restoring arterial oxygen tension to sea level values reestablishes maximal 530 
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power output and maximal leg VO2 values to those observed at sea level 20. 531 
 532 
The phenomenon where the driving pressures of oxygen diffusion becomes limiting, which then 533 
alters exercise performance, is referred to as the “critical PO2”. More specifically, the critical 534 
PO2 is the theoretical value of arterial oxygen tension where maximal oxygen diffusion becomes 535 
restricted and results in a loss of exercise capacity. The critical PO2 for maximal and submaximal 536 
exercise performance appear to differ 148, 149 though identification of an actual critical PO2 is 537 
lacking. The value has been estimated to occur somewhere from 3,500 m to elevations above 538 
4,000 m 16, 78, 150, elevations that result in PaO2 value less than or equal to 40 mmHg 151, or at 539 
elevations where SaO2 fall to a value ranging from 70 to 75% and below 152. 540 
 541 
Diminishing PO2 concomitant to increasing elevations results in increased diffusion limitations 542 
that are particularly apparent in the lung 144, 153-156, skeletal muscle 114, 154, 157, and though not yet 543 
directly measured, is suggested to play a larger role on central nervous system (CNS) 544 
oxygenation at high to extreme altitudes, more so than the loss of CaO2 152. A loss of exercise 545 
capacity in hypoxia may be explained by a change in fatigue pattern from peripheral to central 546 
mechanisms 158. The transport of oxygen from the environment to the mitochondria is dependent 547 
upon both the capacity to carry oxygen to the metabolically active tissue as well as the pressure 548 
difference to facilitate diffusion to the respiring organelle. Maximal oxidative phosphorylation 549 
capacity of the vastus lateralis in highly trained cyclists was identified as the strongest 550 
determinant of exercise performance at 1,020 m 159. At moderate to high altitudes, an increase in 551 
RCV enhances the total capacity to carry oxygen but its effects on the rate of oxygen diffusion to 552 
respiring cells are small to negligible 157. At altitudes corresponding to or above the critical PO2, 553 
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the declining partial pressure of oxygen results in diffusion limitations from the environment into 554 
the body, e.g., pulmonary, as well as with oxygen unloading to tissues throughout the body, 555 
independent of increases in CaO2, and thus limiting maximal oxygen capacity 119, 139, 154.  556 
 557 
Exercise itself exacerbates altitude-induced hypoxemia, as alveolar to arterial PO2 difference (A-558 
aDO2) is linearly related to exercise intensity. Arterial hypoxemia is primarily attributed to an 559 
excessive exercise-induced widening of the A-aDO2 in which the hyperventilatory response fails 560 
to sufficiently compensate. The effect of the exercise-induced widening of A-aDO2 becomes 561 
more prominent as elevation increases.  23. Exercise-induced A-aDO2 widening strains systemic 562 
buffering capacity, as bicarbonate supplementation abates EIAH 160. Exercise in combination 563 
with the loss of ambient oxygen tension at higher altitudes worsens the limitations of oxygen 564 
diffusion in the lungs, lowering PaO2, reducing SaO2 as well as attendant CaO2, and ultimately 565 
attenuating oxygen delivery to all tissue. Overall the loss of diffusion gradient at the critical PO2 566 
counteract those attributed to a greater convective transport of oxygen, such as greater CaO2, 567 
resulting in negligible changes in maximal exercise capacity 139.    568 
 569 
Diffusion limitations help to explain the seemingly paradoxical effect of a diminished exercise 570 
capacity following acclimatization to high altitudes despite large increases RCV and attendant 571 
CaO2 that exceed values measured at sea level 20. Not one study that utilized acute means of 572 
RCV manipulation demonstrated an increase in VO2max following an increase in RCV above 573 
elevations of 3,600 m 16, 78, 80.  574 
 575 
Studies that examined acclimatization as means of increasing RCV and changes in exercise 576 
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capacity differ from the studies that utilized acute methods of RCV manipulation. Above 577 
elevations of 3,600 m, increases in RCV sometimes correlated to an improvement in VO2max 57, 578 
58, 83 and other times did not 122-124. The critical PO2 is undoubtedly a dynamic rather than static 579 
phenomenon and fluctuates with acclimatization. Diffusive capacity of oxygen does appear to 580 
improve following acclimatization 65 as shown by improvements in PaO2 and SaO2 83, 115, smaller 581 
A-aDO2 gradient 83, 161, 162, greater arteriovenous oxygen difference (a-v O2) 83, 122, and an 582 
improved ratio of minute ventilation (VE) to VO2 at a given workload 62.  583 
 584 
The seemingly inconsistent correlations between RCV and VO2max following acclimatization 585 
may also be attributed to “noise” associated with different tests of maximal exercise used across 586 
studies (Table 1). Individual values of VO2max fluctuate according to subject characteristics such 587 
as degree of acclimatization to the respective elevation, training status, body mass, body 588 
composition, age and gender 163. In well-trained subjects, the loss of VO2max when subjected to 589 
the same absolute increase in elevation exhibits a broad inter-individual variability 30, 106. Level 590 
of training varied greatly among subjects across studies (Table 1). None of the studies provided 591 
data detailing subject training or activity level while exposed to their respective elevations. The 592 
studies that monitored changes in Htc, [Hb], and/or CaO2 alongside exercise performance while 593 
remaining at a specific altitude (extending from 2,270 to 5,260 m) used varying spans of time 594 
(ranging from 2 to 10 weeks) (Table 1). The possibility of confounding factors due to training or 595 
detraining adaptations should be considered with these results and accounted for in future 596 
studies. 597 
 598 
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In general, the data suggests that at elevations in which the critical PO2 has not been met, 599 
maximal exercise is primarily limited via properties of oxygen convection, and an increase in 600 
CaO2 would correlate with concomitant improvements in maximal exercise capacity. One of the 601 
most common mechanisms used to increase CaO2, and the most viable for enhancing exercise, is 602 
by increasing RCV.  603 
 604 
Conclusions 605 
This review elucidates the role of RCV on performance at altitude and the underlying 606 
mechanism(s) attributable to the measured outcomes. At 500 to 3,500 m, convective limitations 607 
in oxygen transport primarily govern maximal exercise capacity, and increases in RCV and CaO2 608 
result in greater VO2max. Alternatively at 4,500 m and higher, the decrease in the partial pressure 609 
gradient of oxygen attendant to an increasing elevation leads to a loss of both driving pressure 610 
and rate of oxygen diffusion at the lung as well as the metabolic tissue, ultimately limiting 611 
oxygen consumption and VO2max. At high to extreme altitudes, RCV and any attendant increases 612 
in CaO2 have less influence on exercise capacity when compared to lower elevations. This 613 
explains the seemingly paradoxical findings of how RCV and VO2max do not correlate at 614 
elevations ranging from high(er) to extreme altitudes (approximately 3,500 to 4,500 m and 615 
above). In between 3,500 to 4,500 m exists a critical PO2; a theoretical value of arterial oxygen 616 
tension where maximal oxygen diffusion becomes restricted resulting in a loss of exercise 617 
capacity. The critical PO2 is dependent upon acclimatization, gender, and individual training 618 
status. Future research shall attempt to elucidate limitations in oxygen transport and pinpoint a 619 
critical PO2 by manipulating RCV and PaO2, while maintaining CaO2, to explain oxygen flux 620 
limitations during maximal exercise in various environments. 621 
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Table 1 982 
Study Sample size 
Elevation 
(or simulated 
elevation) 
Method of RCV 
Manipulation 
Method of Maximal 
Exercise Test 
Method of 
Endurance Test Δ Htc 
Δ [Hb] 
(g/dl) 
Δ CaO2 
(ml/dl) 
Δ  WB 
VO2max 
Δ Endurance 
Capacity 
Pugh, 1967 n = 6 4 weeks at 2,270 m 
Natural 
acclimatization 
Incremental series of 
exercise in 5 min 
blocks 
Running time 
trials: 
4.8 and 1.6 km 
0.444 to 
0.476 
↑ 7.2% 
Not 
reported 
Not 
reported 
3.23 to 3.41 
l∙min
-1
 
↑ 5.6% 
↑ 2.6% (23 
sec) for 4.8 
km, 
 ↑1.8% (4.9 
sec) 
for 1.6 km 
Horstman et 
al., 1980 n = 9 
15 to16 days 
exposure at 
4,300 m 
Natural 
acclimatization 
Series of 4 brief 
incremental treadmill 
tests 
Time until fatigue 
at 86% hypoxic 
VO2max 
0.479 to 
0.540 
↑ 12.7% 
Not 
reported 
16.8 to 
19.9 
↑ 18.5% 
35.3 to 38.8 
ml∙kg
-1
∙min
-1
 
↑ 9.9% 
51.1 to  
81.4 min 
↑ 59.3% 
Tufts et al., 
1985 
Anemic: 
n = 10 
Non-anemic: 
n = 46 
Native of 
3,700 m 
High-altitude  
native – long term 
adaptation 
Modified Balke cycle 
ergometer protocol None 
0.42 vs 0.54 
↑ 28.6% 
13.6 vs 
18.9 
↑ 39.0% 
Not 
reported 
2.12 vs 2.69 
l∙min
-1
 
↑ 26.9% 
N/A 
Bender et 
al., 1988 n = 7 
15 to 17 days 
exposure at 
4,300 m 
Natural 
acclimatization 
Incremental 
cycle ergometer 
protocol 
3-5 minutes at 43, 
70, and 95% 
normoxic 
VO2max 
Not reported 
14.3 to 
17.2 
↑ 20.3% 
16.1 to 
20.8 
↑ 29.2% 
2.52 to 2.49 
l∙min
-1
 
↓ 1.2% NS 
↑ a-v O2, 
↑ PaO2, 
 ↑ SaO2, ↓ 
LBF, ↔ O2 
delivery 
Boutellier et 
al., 1990 n = 6 
3 weeks at 
5,200 m 
Natural 
acclimatization 
Extrapolation via 
HR/VO2 relationship 
& HRmax 
None 
Approx 
0.501 to 
0.556 
↑ 10.9% 
16.4 to 
18.2 
↑ 11.0% 
Not 
reported 
36.9 to 38.4 
ml∙kg
-1
∙min
-1
 
↑ 4.1% NS 
N/A 
Grassi et al., 
1996 n = 10 
1 week vs. 
5 weeks at 
5,050 m 
Natural 
acclimatization 
Incremental 
cycle ergometer 
protocol 
None Not reported 
17.4 to 
18.8 
↑ 8.0% 
Not 
reported 
1.89 to 2.14 
l∙min
-1
 
↑ 13.2% NS 
N/A 
Calbet et al., 
2003b 
n = 7 
(3 female, 
4 male) 
9 to 10 weeks 
 at 5,260 m 
Natural 
acclimatization 
Incremental 
cycle ergometer 
protocol 
Constant load  
test between 
102 to 140 W 
Measured but 
not reported 
13.8 to 
18.0 
↑ 30.4% 
16.6 to 
21.8 
↑ 31.3% 
2.12 to 2.4 
l∙min
-1
 
↑ 13.2% 
↓ HR,  
↑ a-v O2, 
↑ O2 delivery 
Schuler et 
al., 2007 n = 8 
14 days  
exposure at  
2,340 m 
Natural 
acclimatization 
Incremental 
cycle ergometer 
protocol 
Constant load 
 test at 80% 
 normoxic VO2max 
0.404 to 
0.446 
↑ 10.4% 
13.1 to 
14.6 
↑ 11.5% 
16.5 to 
18.4 
↑ 11.5% 
4.25 to 4.60 
l∙min
-1
 
↑ 8.2% 
31.66 to  
35.46 min 
↑ 12.0% 
Prommer et 
al., 2007 
Sea Level: 
(n = 15) 
Intermittent 
Hypoxia: 
(n = 15) 
SL: Sea level for 
6 months, 
IH: Hypoxic– 
normoxic cycles 
of 11 days at 
3,550 m and 
3 days at sea level 
for 6 months 
Natural 
acclimatization 
Incremental cycle 
ergometer protocol at 
3,550m 
None 
0.467 vs 
0.487 
↑ 4.3% NS 
Total 
Hbmass (g) 
751 vs 
836 
↑ 11.3% 
18.4 vs 
20.2 
↑ 9.8% 
42.5 vs 41.7 
ml∙kg
-1
∙min
-1
 
↓ 1.9% NS 
N/A 
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Table 2 985 
Study Sample size 
Elevation  
(or simulated 
elevation) 
Method of RCV 
Manipulation 
Method of Maximal 
Exercise Test 
Method of 
Endurance Test Δ Htc 
Δ [Hb] 
(g/dl) 
Δ CaO2  
(ml/dl) 
Δ  WB VO
2max
 Δ Endurance 
Capacity 
Horstman et 
al., 1980 n = 5 
20-21 days 
exposure at  
4,300 m 
Isovolemic 
hemodilution 
Series of 4 brief 
incremental  
treadmill tests 
Time until  
fatigue at 86% 
hypoxiaVO
2max
 
0.534 to 
0.477 
↓ 10.6% 
Not 
reported 
19.3 to 
17.6 
↓ 8.8% 
39.2 to 36.0 
ml∙kg
-1
∙min
-1
 
↓ 8.2% 
90.2 to 58.8 min 
↓ 34.8% 
Winslow et al., 
1985 n = 1 
Native of  
4,250 m 
Isovolemic 
hemodilution 
Incremental cycle 
ergometer protocol 
Constant load  
tests at 0 &  
49 W 
0.62 to 
0.42 
↓ 32.3% 
22.4 to 
16.0 
↓ 28.6% 
Not 
reported 
↔ No change 
reported 
Values not 
given 
↑ V
E
, ↑ VO
2
,  
↑ HR, ↑ RER,  
↑ Q 
Boutellier et 
al., 1990  n = 4 
5 weeks at 
5,200 m 
Hemodilution via oral 
ingestion of isomolar 
solution 
Extrapolation via 
HR/VO
2
 relationship  
& HR
max
 
None 
Approx 
0.556 to 
0.543 
↓ 2.3% 
Not 
reported 
Not 
reported 
38.2 to 35.4 
ml∙kg
-1
∙min
-1
↓ 
7.3% 
N/A 
Schaffartzik et 
al., 1993 n = 7 
Acute 
FiO
2
: 12.0%; 
4,300 m 
Isovolemic 
hemodilution 
Incremental cycle 
ergometer protocol None 
0.495 to  
not 
reported 
↓ ?% 
15.9 to 
13.8 
↓ 13.2% 
17.1 to 
15.6 
↓ 8.8% 
Leg VO
2max
; 
0.96 to 0.83 
l∙min
-1
  
↓13.5% 
N/A 
Roach et al., 
1999 n = 7 
Acute 
FiO
2
: 11.0%; 
5,000 m 
Isovolemic 
hemodilution 
Incremental knee-
extensor contractions None 
Approx 
0.43 to 
0.34 
↓ 20.9% 
Approx 
14.3 to 
11.5 
↓19.6% 
Approx 
16.4 to 
13.3 
↓ 18.9% 
2.11 to 1.70  
l∙min
-1
 
↓ 19.4% 
N/A 
Calbet et al.,  
2002 n = 8 
9 weeks at 
5,260 m 
Isovolemic 
hemodilution 
Incremental cycle 
ergometer protocol 
Constant load  
test at 120 W 
0.52 to 
0.39 
↓ 25% 
18.5 to 
14.2 
↓ 23.2% 
22.2 to 
17.1 
↓ 23.0% 
Approx 2.48 to  
2.40 l∙min
-1
 
↓ 3.2%, NS 
↑ HR, ↑ 2LBF,  
↑ Q, ↑ SVC & 
LVC, ↓ MAP  
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 988 
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Table 3 994 
Study Sample  size 
Elevation  
(or simulated 
elevation) 
Method of RCV 
Manipulation 
Method of 
Maximal 
Exercise Test 
Method of 
Endurance Test Δ Htc 
Δ [Hb] 
(g/dl) 
Δ CaO
2 
 
(ml/dl) 
Δ  WB 
VO
2max
 
Δ Endurance 
Capacity 
Pace et al., 1945 
RBC Tx: 
n = 5 
Saline 
Tx:  
n = 5 
Intermittent 
hypobaric 
hypoxia 
4,724 m 
Blood infusion 
2000 mL (50% RBC; 
1000 ml) 
None Submaximal walking test 
Approx  
0.46 vs 
0.59 
↑ 28.3% 
Not 
reported 
Approx   
14.2 vs 
17.5 
↑ 23.2% 
N/A 
Lower HR 
walking at submax 
intensity 
Robertson et al., 
1982 n = 5 
Acute 
FiO
2
: 13.5%; 
3,566 m 
RBC reinfusion 
750 ml (70% RBC; 
525 ml) 
Bruce multistage 
treadmill protocol 
TTE @ 75% 
normoxic  
pre-infusion VO
2max
 
0.433 to 
0.548 
↑ 26.6% 
13.8 to 
17.6  
↑ 27.5% 
Not 
reported 
2.62 to 2.96  
l∙min
-1
 
↑ 13.0% 
687 to 748 sec 
↑ 8.9% 
Robertson et al., 
1984 n = 9 
Acute 
FiO
2
: 16.0% 
2,255 m 
RBC reinfusion 
475 ml (70% RBC; 
334 ml) 
Multistage cycle 
ergometer 
protocol 
Exercise at 70% 
normoxic pre-
infusion VO
2max
 
0.381 to 
0.449 
↑ 17.8% 
12.7 to 
14.7 
↑ 15.7% 
Not 
reported 
Approx 2.15 
to 2.37 
l∙min
-1
 
↑ 10.2% 
HR ↓12.2% 
[La]  ↓ 27.4%  
Young et al., 
1996 & Pandolf et 
al., 1998 
Control, 
n = 8; 
RBC 
infused,  
n = 8 
1 to 3 days 
exposure at 
4,300 m 
RBC reinfusion 700 
ml (42% RBC; 295 
ml) 
Incremental 
treadmill protocol 
Time to complete 3.2 
km run 
Not 
reported 
Approx 
14.3 vs 
15.6 
↑ 9.1% 
Approx 
16.7 vs 
18.3 
↑ 9.6%,  
p = 0.55 
3.11 vs 3.34  
l∙min
-1
 
↑ 7.4%, NS 
1,184 vs.  
1,142 sec 
↓ 3.5%, NS 
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 996 
 997 
 998 
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 1002 
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Table 4 1005 
Study Sample  size 
Elevation  
(or simulated 
elevation) 
Method of RCV 
Manipulation 
Method of Maximal 
Exercise Test 
Method of 
Endurance Test Δ Htc
* Δ [Hb] (g/dl)* 
Δ CaO2  
(ml/dl)* 
Δ  WB 
VO
2max
 
Δ 
Endurance 
Capacity 
Lundby et 
al., 2006 n = 10 
Acute 
FiO
2
: 12.4%; 
4,100 m 
4 weeks NESP 
treatment 
Incremental cycle 
ergometer protocol 
15 min submax;  
100 W  female,  
150 W male 
0.42 to 0.49 
↑ 16.7% 
13.8 to 16.8 
↑ 21.7% 
17.2 to 19.2 
↑ 11.6% 
3.12 to 3.12  
l∙min
-1
 
↔ 0%, NS 
↓[La]  18.4% 
↓ RER 8.5% 
Robach et al., 
2008 n = 7 
Acute 
FiO
2
: 17.4%; 
1,500 m 
5 weeks rhEpo 
treatment 
Incremental cycle 
ergometer protocol None 
0.477 to 0.519 
↑ 8.8% 
15.5 to 17.1 
↑ 10.3% 
18.7 to 20.7 
↑ 10.7% 
Approx  
↑ 9.1% N/A 
Robach et al., 
2008 n = 7 
Acute 
FiO
2
: 15.3% 
2,500 m 
5 weeks rhEpo 
treatment 
Incremental cycle 
ergometer protocol None 
0.482 to 0.514 
↑ 6.6% 
15.8 to 16.8 
↑ 6.3% 
18.0 to 19.1 
↑ 6.1% ↑ 14.0% N/A 
Robach et al., 
2008 n = 7 
Acute 
FiO
2
: 13.4%; 
3,500 m 
5 weeks rhEpo 
treatment 
Incremental cycle 
ergometer protocol None 
0.474 to 0.523 
↑ 10.3% 
15.6 to 16.9 
↑ 8.3% 
16.2 to 18.0 
↑ 11.1% ↑ 17.5% N/A 
Robach et al., 
2008 n = 7 
Acute 
FiO
2
: 11.5%; 
4,500 m 
5 weeks rhEpo 
treatment 
Incremental cycle 
ergometer protocol None 
0.481 to 0.508 
↑ 5.6% 
15.5 to 16.8 
↑ 8.4% 
14.7 to 15.3 
↑ 4.1%, 
NS 
↑ 1.9%, NS N/A 
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Table 5 1006 
Variable % Δ at 1,500 m % Δ at 2,500 m % Δ at 3,500 m % Δ at 4,500 m 
Htc ↑ 8.8* ↑ 6.6* ↑ 10.3* ↑ 5.6* 
CaO2 ↑ 10.7* ↑ 6.1* ↑ 11.1* ↑ 4.1
NS
 
VO2max ↑ 9.1* ↑ 14.0* ↑ 17.5* ↑ 1.9
NS
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 1025 
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Table Legends 1028 
 1029 
Table 1. Summary of studies that have examined the effect of acclimatization on exercise capacity. 1030 
NS = not significant (unless specified, all data presented represents a significant change); RCV = red 1031 
blood cell volume; Δ = change; Htc = percent Htc; [Hb] = Hb concentration; CaO2 = arterial oxygen 1032 
content; WB = whole body; VO2max = maximal oxygen consumption; N/A = not applicable; LBF = 1033 
leg blood flow; HR = heart rate; VO2 = volume of oxygen consumed; [La] = lactate concentration; 1034 
W = Watts; a-v O2 = arteriovenous oxygen difference; SL = sea level; IH = intermittent hypoxia; 1035 
and Hbmass = total hemoglobin mass. 1036 
 1037 
Table 2. Summary of studies that have examined the effect of hemodilution on exercise capacity in 1038 
a hypoxic environment. NS = not significant (unless specified, all data presented represents a 1039 
significant change); RCV = red blood cell volume; Δ = change; Htc = percent Htc; [Hb] = Hb 1040 
concentration; CaO2 = arterial oxygen content; WB = whole body; VO2max = maximal oxygen 1041 
consumption; N/A = not applicable; kpm = kilopond per meter; VE = minute ventilation; HR = heart 1042 
rate; RER = respiratory exchange ratio; Q = cardiac output; FiO2 = fraction of inspired oxygen; W = 1043 
watts; 2LBF = two leg blood flow; SVC = systemic vascular conductance; LVC = leg vascular 1044 
conductance; and MAP = mean arterial pressure. 1045 
 1046 
Table 3. Summary of studies that have examined the effect of red blood cell volume (RCV) on 1047 
exercise capacity in a hypoxic environment. NS = not significant (unless specified, all data 1048 
presented represents a significant change); Δ = change; Htc = percent Htc; [Hb] = Hb concentration; 1049 
CaO2 = arterial oxygen content; WB = whole body; VO2max = maximal oxygen consumption; Tx = 1050 
49 
treatment; HR = heart rate; N/A = not applicable; [La] = lactate concentration; FiO2 = fraction of 1051 
inspired oxygen; and TTE = time to exhaustion. 1052 
 1053 
Table 4. Summary of studies that have examined the effect of erythropoietic stimulating agent 1054 
(ESA) on exercise capacity in a hypoxic environment. *Values obtained during maximal exercise. 1055 
NS = not significant (unless specified, all data presented represents a significant change); RCV = red 1056 
blood cell volume; Δ = change; Htc = percent Htc; [Hb] = Hb concentration; CaO2 = arterial oxygen 1057 
content; WB = whole body; VO2max = maximal oxygen consumption; NESP = novel erythropoiesis 1058 
stimulating protein; rhEpo = recombinant human erythropoietin; W = watts; RER = respiratory 1059 
exchange ratio; N/A = not applicable; [La] = lactate concentration; and FiO2 = fraction of inspired 1060 
oxygen. 1061 
 1062 
Table 5. Changes in hematopoietic characteristics and maximal oxygen consumption at various 1063 
degrees of hypoxic exposure. *P < 0.05 pre recombinant human erythropoietin (rHuEpo) treatment 1064 
versus post rHuEpo treatment. Percent hematocrit = Htc; Δ = change; CaO2 = arterial oxygen 1065 
content; and VO2max = maximal oxygen consumption. Data obtained from reference 16. 1066 
 1067 
 1068 
 1069 
 1070 
 1071 
 1072 
 1073 
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Figure Legends 1074 
 1075 
Figure 1. Relationship between maximal aerobic capacity (VO2max) and percent hematocrit (Htc) in 1076 
wild type mice following either injection with erythropoietic stimulating agent (ESA) or blood 1077 
withdrawal. Adapted from reference 44. 1078 
 1079 
Figure 2A-C. Correlation between percent hematocrit (Htc) and A. maximal oxygen consumption 1080 
(VO2max); B. maximal power output in Watts (W); and C. time to exhaustion (TTE). Data obtained 1081 
from reference 82. Individual subject responses (n = 7) for maximal power output (A), VO2max (B) 1082 
and TTE (C) during constant-load cycling. Subjects were tested at sea level and again on days 1, 7, 1083 
14 and 21 after arrival at 2,340 m. 1084 
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